Document is current
Any future updates will be listed below
-
Authors
Abu, Hawa O.
del Castillo, Felipe Fernandez
Wang, Weijia
Saczynski, Jane S.
Mehawej, Jordy
Tenes, Paul
Tisminetzky, Mayra
Gurwitz, Jerry
Goldberg, Robert J.
Dosa, David
Kapoor, Alok
McManus, David D.
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (3R01HL155343-04S1)
National Heart, Lung, and Blood Institute (R01HL126911)
National Heart, Lung, and Blood Institute (3R01HL155343-04S1)
National Heart, Lung, and Blood Institute (R01HL126911)
- License Information
-
More Information
Article History
Received: 19 December 2024
Accepted: 3 December 2025
First Online: 28 December 2025
Declarations
:
: The Institutional Review Boards at the participating study sites including the University of Massachusetts Medical School, Boston University, and Mercer University, provided ethical approval for conducting this study. All study participants provided written informed consent. Given our observational study design, no experiments were conducted on the study participants.
: Not applicable.
: David McManus has received research grant support from Apple Computer, Bristol‐Myers Squibb, Boeringher‐Ingelheim, Pfizer, Samsung, Philips Healthcare, and Biotronik; consultancy fees from Bristol‐Myers Squibb, Pfizer, Flexcon, and Boston Biomedical Associates, and has inventor equity in Mobile Sense Technologies, Inc (Farmington, CT). All other authors declare no potential conflicts of interest.
